Iovance Biotherapeutics (NASDAQ: IOVA) is getting a welcome boost after Australia signed off on its flagship melanoma therapy, adding another pillar to the company’s global…
Iovance Biotherapeutics (NASDAQ: IOVA) is getting a welcome boost after Australia signed off on its flagship melanoma therapy, adding another pillar to the company’s global…